Skip to content
BOFA GLOBAL RESEARCH

GLP-1s are shrinking some appetites; broader use poses a prickly challenge

Share

At a Glance

The desk views the emergence of lower-priced GLP-1 therapies as pivotal for future growth in the healthcare sector, particularly affecting food and beverage industries, as outlined by BofA Global Research. With penetration levels currently around 10%, there is significant potential for increases as pricing decreases and the adoption of oral formulations accelerates. Current pricing adjustments suggest that a robust runway for unit growth will enable GLP-1s to capture greater market share. The implications for the FX market may be profound, particularly for currencies linked to healthcare spending or consumer goods exports, as these sectors respond to the shifts in consumer behavior driven by the growing acceptance of GLP-1 therapies.

Key Takeaways

  • 01Lower GLP-1 pricing is expected to drive increased market penetration in healthcare.
  • 02Current adoption rates around 10% are just the beginning of expected growth.
  • 03Food and beverage sectors may experience significant shifts as GLP-1 therapies gain traction.
  • 04The competitive landscape among GLP-1 medications is intensifying, necessitating careful monitoring.

Full Analysis

What the desk is arguing

The desk argues that the combination of lower pricing and increased availability of oral GLP-1 drugs will accelerate their market penetration. Per the full note from BofA Global Research, the current ~10% penetration rate presents a significant growth opportunity for these therapies as pricing trends downward.

Evidence indicates that this new phase of GLP-1 integration is poised to challenge food and beverage companies, as consumer behavior shifts in response to the weight loss benefits of these medications. Analysts at BofA highlight that the current landscape suggests ample room for growth, especially as competition intensifies among GLP-1 products, leading to improvements in side-effect profiles and overall acceptance.

Where it sits in our coverage

The consensus target for the relevant currency pair is 1.075, within a range of 1.04 to 1.12. Notable targets from specific firms include: - jpmorgan: 1.10 (Mar26) - bofa: 1.04 (Mar26)

The desk's view aligns more closely with jpmorgan, sitting near the upper end of the consensus range, indicating a bullish outlook on the implications of GLP-1 growth on the consumer expenditure landscape.

How other firms see it

Firms such as jpmorgan are aligned with the desk's optimistic assessment of market penetration, while bofa holds a contrary view, anticipating more restrained growth potential. This divergence highlights differing perspectives on the sustainability of current pricing trends and their effects on consumer behavior.

The trajectory of the EUR/USD may also reflect broader market trends as healthcare reforms and consumer spending behaviors are influenced by developments within the GLP-1 segment.

Market Implications

Traders should monitor how the trend in lower GLP-1 pricing affects consumer goods exports and related currency pairs. A key level to watch is 1.075, as movements toward or away from this point may signal broader shifts in market sentiment.

From the original

Lower prices are unlocking the next leg of GLP-1 growth Several years ago, the bullish case for GLP-1 penetration hinged on lower pricing and the availability of oral options-both of these have materialized over the past 18 months. Yet we remain early in the oral GLP-1 ramp, and

Related speeches

4 items
ING THINKMay 18, 2026

Makary’s successor faces tough task managing FDA amid budget cuts

The desk contends that the recent budget cuts at the FDA, attributed to the Trump administration, are likely to precipitate medicine shortages and stifle innovation within the healthcare sector. Per the full note [source], the challenges facing Marty Makary's successor as FDA commissioner will hinder the agency's capabilities and reform initiatives. Ongoing developments in this regulatory landscape could create volatility in healthcare equities and related currency pairs, with potential spillover effects spilling into broader FX markets.

DESK NOTEUBS GWM, Chief Economist - Paul DonovanMay 20, 2026

UBS Morning audio comment: Capping inflation

The UBS commentary emphasizes the rising prices of politically sensitive goods and the pressure on politicians to act, particularly in light of increasing inflation rates. Per the full note, these pressures suggest potential shifts in fiscal and monetary policy as governments aim to address public concerns. Such measures could influence market expectations, particularly in the currency space, as traders anticipate potential interventions from central banks. With no immediate high-impact events on the horizon, traders will need to closely monitor any statements or actions from policymakers that could signal a change in the current economic environment.

BOFA GLOBAL RESEARCHBofA Global ResearchJun 2, 2026

Must Read Research: Size of the Market, World Cup & Paper Goods, Energy Contingencies, and LatAm Elections

Current discourse surrounding global economic activity highlights the expanding market dynamics as catalysts for rising global beverage demand, significantly fueled by events such as the World Cup. Per the full note from BofA Global Research, ongoing changes in energy strategies are prompting contingency planning which affects commodity markets and consumer behavior. This evolving landscape suggests a potential impact on currency valuations as different regions respond to these changes. As we look ahead, the interactions between geopolitical events and economic indicators will be crucial for guided trading decisions.

DESK NOTEING EconomicsMay 19, 2026

Rates Spark: Markets have shifted to a broader inflation impact

The desk's thesis revolves around the recent shift in market perceptions regarding inflation's broader impact on economic conditions. Per the full note from ING Economics, recent data has indicated a more persistent inflation trajectory, compelling markets to recalibrate their expectations surrounding central bank policy responses. Central banks, in turn, may need to adopt a more aggressive stance as inflation proves to be less transitory than initially perceived, with several indicators pointing to elevated prices persisting across various sectors. This sets the stage for potential volatility across currency pairs, particularly in response to macroeconomic updates as inflation data is likely to drive market sentiment.

More from BOFA GLOBAL RESEARCH

5 items

FX Bank Forecast aggregates and synthesises central-bank commentary. Sentiment scoring and bank tagging are heuristic — verify against the original source before trading. We do not endorse third-party content.

FX BANK FORECAST · COVERAGE

Institutional FX coverage in your inbox

Aggregated year-end forecasts, scenario shifts, and curated analyst notes from eight institutional desks. No promotion.